相关实验视频

Updated: Jun 21, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

针对膀癌的NK细胞向免疫疗法:超越检查点抑制剂

Yuanshuo A Wang^1,2,3,4, Daniel Ranti^1,2,3,4, Christine Bieber^1,2,3,4

¹The Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Bladder cancer (Amsterdam, Netherlands)

|July 12, 2024

概括

自然杀手 (NK) 细胞为增强膀癌免疫疗法提供了一个有希望的途径. 利用NK细胞功能可以改善目前的治疗方法,克服T细胞集中治疗的局限性.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
癌症治疗癌症治疗

背景情况:

免疫疗法,包括免疫检查点抑制剂 (ICI),对于膀癌治疗至关重要.
现有的针对T细胞的ICI显示出有限的响应率,需要补充策略.
自然杀手 (NK) 细胞由于其快速,受体介导的抗瘤活性而呈现出有前途的方法.

研究的目的:

审查目前针对膀癌的NK细胞向免疫疗法.
探索诸如工程病毒载体,小分子,NK激进抗体,介质蛋白和CAR-NK细胞等策略.
评估它们在膀癌中增强免疫疗法疗效的潜力.

主要方法:

关于NK细胞在固体瘤和血液恶性瘤中的作用的文献综述.
概述了针对膀癌的NK细胞基础免疫疗法的知识.
确定了利用NK细胞功能的新型治疗策略.

主要成果:

NK细胞显著影响瘤微环境 (TME).
利用NK细胞功能可以增强针对T细胞的免疫疗法.
NK细胞的活性由HLA类I,KIR和NKG2A受体进行调节.

结论:

NK细胞是改善膀癌免疫治疗的关键目标.
进一步研究NK细胞概况可以确定NK向治疗的最佳患者候选人.
利用NK细胞的抗瘤特性具有显著的治疗潜力.

关键词:

膀癌是一种癌症.在 NK 细胞中, NK 细胞是最重要的.免疫疗法免疫疗法

更多相关视频

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...